NO852885L - Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater.

Info

Publication number
NO852885L
NO852885L NO852885A NO852885A NO852885L NO 852885 L NO852885 L NO 852885L NO 852885 A NO852885 A NO 852885A NO 852885 A NO852885 A NO 852885A NO 852885 L NO852885 L NO 852885L
Authority
NO
Norway
Prior art keywords
pyridobenzoksazin
naftyridine
quinolone
derivatives
preparation
Prior art date
Application number
NO852885A
Other languages
English (en)
Other versions
NO171638C (no
NO171638B (no
Inventor
Thomas F Mich
Joseph P Sanchez
John M Domagala
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO852885L publication Critical patent/NO852885L/no
Publication of NO171638B publication Critical patent/NO171638B/no
Publication of NO171638C publication Critical patent/NO171638C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO852885A 1984-07-20 1985-07-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater NO171638C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63315384A 1984-07-20 1984-07-20

Publications (3)

Publication Number Publication Date
NO852885L true NO852885L (no) 1986-01-21
NO171638B NO171638B (no) 1993-01-04
NO171638C NO171638C (no) 1993-04-14

Family

ID=24538490

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852885A NO171638C (no) 1984-07-20 1985-07-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater

Country Status (18)

Country Link
EP (1) EP0172651B1 (no)
JP (2) JPH0791288B2 (no)
KR (1) KR900003495B1 (no)
AR (1) AR241183A1 (no)
AT (1) ATE50255T1 (no)
AU (3) AU576252B2 (no)
CA (1) CA1331381C (no)
DE (1) DE3575924D1 (no)
DK (3) DK302885A (no)
ES (3) ES8704161A1 (no)
FI (1) FI83648C (no)
GR (1) GR851648B (no)
IE (1) IE58742B1 (no)
NO (1) NO171638C (no)
NZ (1) NZ212805A (no)
PH (3) PH22341A (no)
PT (1) PT80836B (no)
ZA (1) ZA855038B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
ATE75740T1 (de) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
AU594983B2 (en) 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
DE3635846C2 (de) * 1986-10-22 1995-08-03 Teves Gmbh Alfred Blockiergeschützte Bremsanlage mit Antriebsschlupfregelung
JPS63185607A (ja) * 1987-01-27 1988-08-01 Matsushita Electric Works Ltd シ−ト状成形材料の製法
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US4839355A (en) * 1987-09-09 1989-06-13 Sterling Drug Inc. Tricyclic-pyridinylquinoline compounds, their preparation and use
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
KR910003630B1 (ko) * 1988-06-17 1991-06-07 한국과학기술원 벤조일 아세틱 에스테르 유도체 및 그 제조방법
JPH0674261B2 (ja) * 1988-06-21 1994-09-21 塩野義製薬株式会社 キノロンカルボン酸誘導体
WO1990002123A1 (en) * 1988-08-23 1990-03-08 Pfizer Inc. Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
US5286723A (en) * 1988-08-31 1994-02-15 Daiichi Seiyaku Co., Ltd. Spiro compound
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
AU640481B2 (en) 1990-04-18 1993-08-26 Norwich Eaton Pharmaceuticals, Inc. Penicillan or cephalosporin derivatives of quinolonyl
DE4032560A1 (de) * 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
CA2099591C (en) * 1990-12-05 2002-11-12 Rajeshwar Singh 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3- carboxylic acid compounds useful as antibacterial agents
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
TW252107B (no) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
CA2210007A1 (en) * 1995-01-24 1996-08-01 Yasuo Ito Quinoline carboxylic acid
EP1666477B1 (en) * 2003-09-10 2013-07-03 Kyorin Pharmaceutical Co., Ltd. 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) q uinolonecarboxylic acid derivative
US7563805B2 (en) * 2005-05-19 2009-07-21 Daiichi Pharmaceutical Co., Ltd. Tri-, tetra-substituted-3-aminopyrrolidine derivative
WO2008143343A1 (ja) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. １４位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
USD808799S1 (en) 2015-11-17 2018-01-30 Hunter Fan Company Carton with color striping

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS57149286A (en) * 1981-03-13 1982-09-14 Dai Ichi Seiyaku Co Ltd 8-aminopyrido(1,2,3-de)(1,4)banzoxazine derivative
JPS58174367A (ja) * 1982-04-07 1983-10-13 Tanabe Seiyaku Co Ltd キノリン誘導体及びその製法
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
DK6193A (da) 1993-01-19
EP0172651B1 (en) 1990-02-07
IE851666L (en) 1986-01-20
ES545390A0 (es) 1987-03-16
AU576252B2 (en) 1988-08-18
PT80836B (pt) 1987-09-30
FI852624L (fi) 1986-01-21
FI83648C (fi) 1991-08-12
CA1331381C (en) 1994-08-09
IE58742B1 (en) 1993-11-05
ATE50255T1 (de) 1990-02-15
ES8800245A1 (es) 1987-10-16
JPH0791288B2 (ja) 1995-10-04
PH24824A (en) 1990-10-30
NO171638C (no) 1993-04-14
JPH0748354A (ja) 1995-02-21
AU1731388A (en) 1988-09-15
DK171935B1 (da) 1997-08-18
AU4458185A (en) 1986-01-23
JPS6143186A (ja) 1986-03-01
AU1731288A (en) 1988-08-25
PH23474A (en) 1989-08-07
AU613372B2 (en) 1991-08-01
PH22341A (en) 1988-08-12
JPH0826003B2 (ja) 1996-03-13
KR860001110A (ko) 1986-02-22
ES554376A0 (es) 1987-10-16
ES554375A0 (es) 1987-10-16
AU602585B2 (en) 1990-10-18
FI83648B (fi) 1991-04-30
DK302885A (da) 1986-01-21
ZA855038B (en) 1986-02-26
GR851648B (no) 1985-11-26
NZ212805A (en) 1989-01-06
AR241183A1 (es) 1992-01-31
DK28892D0 (da) 1992-03-04
KR900003495B1 (ko) 1990-05-21
ES8800244A1 (es) 1987-10-16
DK6193D0 (da) 1993-01-19
FI852624A0 (fi) 1985-07-03
PT80836A (en) 1985-08-01
DK28892A (da) 1992-03-04
NO171638B (no) 1993-01-04
ES8704161A1 (es) 1987-03-16
DE3575924D1 (de) 1990-03-15
DK302885D0 (da) 1985-07-03
EP0172651A1 (en) 1986-02-26

Similar Documents

Publication Publication Date Title
NO852885L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolon- og pyridobenzoksazin-derivater.
NO161370C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO167142C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO167384C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO159446C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO832431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO165023C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoksazol- og furan derivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO162721C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO864131D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO163486C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees